That report followed the announcement by AnGes that animal trials of the vaccine had confirmed an increase in antibodies in tests it had been conducting with Osaka University since March.
“We will examine the results of the toxicity data and swiftly move forward to clinical trials,” AnGes said in a statement Monday.
DNA vaccines are a novel type of vaccine that use genetic material from pathogens to produce antibodies by inducing an immune system response. Such a vaccine has yet to be approved for human use anywhere in the world, but the technology has attracted attention for their purported safety and ease of large-scale manufacturing.